Home

Enliven Therapeutics, Inc. - Common Stock (ELVN)

21.91
+2.25 (11.44%)
NASDAQ · Last Trade: Jun 14th, 3:01 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END
Via FinancialNewsMedia · October 4, 2024